Percutaneous Mechanical Circulatory Support Devices

Similar documents
Introduction to Acute Mechanical Circulatory Support

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Management of Acute Shock and Right Ventricular Failure

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)

Ventricular Assisting Devices in the Cathlab. Unrestricted

Mechanics of Cath Lab Support Devices

Circulatory Support: From IABP to LVAD

Mechanics of Cath Lab Support Devices

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Cardiogenic Shock in Acute MI

Recovering Hearts. Saving Lives.

Bridging With Percutaneous Devices: Tandem Heart and Impella

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

Assist Devices in STEMI- Intra-aortic Balloon Pump

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

AllinaHealthSystem 1

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

Extra Corporeal Life Support for Acute Heart failure

DECLARATION OF CONFLICT OF INTEREST

Understanding the Pediatric Ventricular Assist Device

ST-Elevation Myocardial Infarction & Cardiogenic Shock. - What Should We Do?

LV Distension and ECLS Lungs

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017

How to do Primary Angioplasty. - Patients with Cardiogenic Shock

The World s Smallest Heart Pump

Guideline compliance, utilization trends

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Acute Mechanical Circulatory Support Right Ventricular Support Devices

Rhondalyn C. McLean. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VII, A. Study Purpose and Rationale

Cardiogenic Shock. Carlos Cafri,, MD

Disclosures. Objectives 10/11/17. Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock. I have no disclosures to report

Impella Ins & Outs. CarVasz November :45 12:15

Ted Feldman, M.D., MSCAI FACC FESC

Acute Myocardial Infarction Complicated by Cardiogenic Shock

Case - Advanced HF and Shock (INTERMACS 1)

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

Who is the high risk patient?

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Cardiogenic Shock Protocol

Update on Mechanical Circulatory Support. AATS May 5, 2010 Toronto, ON Canada

Emergency Medical Training Services Emergency Medical Technician Basic Program Outlines Outline Topic: CARDIAC EMERGENCIES Revised: 11/2013

Detailed Order Request Checklists for Cardiology

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery

CABG for ischemic cardiomyopathy, post myocardial infarction and cardiogenic shock

Medical Management of Acute Heart Failure

SUPPLEMENTAL MATERIAL

Andrew Civitello MD, FACC

Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support

Difficult Data Definitions and Scenario s

Definition. Low-cardiac-output state resulting in life threatening end-organ hypoperfusion. Criteria: MAP 30 mm Hg lower than baseline)

Cardiogenic Shock and Initiatives to Reduce Mortality

Which mechanical assistance for cardiogenic shock?

A National Cardiogenic Shock Initiative (CSI):

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio

CENTRAL ECMO WHEN AND HOW? RANJIT JOHN, MD UNIVERSITY OF MINESOTA

CARDIOGENIC SHOCK. Antonio Pesenti. Università degli Studi di Milano Bicocca Azienda Ospedaliera San Gerardo Monza (MI)

Pulmonary Hypertension: Another Use for Viagra

Giving your heart strength. Ventricular Assist Device.

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management

เอกราช อร ยะช ยพาณ ชย

Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support

PUMP FAILURE COMPLICATING AMI: ISCHAEMIC VSR

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

Acute Circulatory Support Should We or Shouldn t We?

High Risk PCI for Heart Failure

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

Percutaneous mechanical circulatory support for treatment and prevention of hemodynamic instability Engström, A.E.

Echocardiography as a diagnostic and management tool in medical emergencies

Right Ventricular Failure: Prediction, Prevention and Treatment

Management of Cardiogenic shock. Prof. Christian JM Vrints

Acute Coronary Syndrome. Sonny Achtchi, DO

3 European Journal of Heart Failure 2016; 18,

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013

VENTRICULAR ASSIST DEVICES AND TOTAL ARTIFICIAL HEARTS

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Mechanical Cardiac Support and Cardiac Transplant: The Role for Echocardiography

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

Cardiac Emergencies. A Review of Cardiac Compromise. Lawrence L. Lambert

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation.

Relax and Learn At the Farm 2012

The majority of patients with cardiomyopathy

headline a Protected PCI Program: Treating the Most Complex Patients

MODULE 2 THE CLINICAL ENIGMA: RANDOMIZED TRIALS vs CLINICAL PRACTICE. Nico H. J. Pijls, MD, PhD Catharina Hospital Eindhoven The Netherlands

DEMYSTIFYING VADs. Nicolle Choquette RN MN Athabasca University

Pre-discussion questions

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

206 Recent Developments in Intensive

Cardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention

Transcription:

Percutaneous Mechanical Circulatory Support Devices Daniel Vazquez RN, RCIS Miami Cardiac & Vascular Institute

FINANCIAL DISCLOSURES none

CASE STUDY

CASE STUDY 52 year old gentlemen Complaining of dyspnea after eating for one week Smallest amounts of food make him bloated He has been walking after meals to help relieve symptoms becomes increasingly short of breath develops significant palpitations Bedtime, becomes markedly SOB, must sleep sitting up Denies any dizziness or chest pain

CASE STUDY NO medical history NO previous surgeries Occasional drinker Occasional smoker Exercised regularly up until symptoms developed Takes only omeprazole which had been providing relief

CASE STUDY June 4th, 2014.. sees his Cardiologist Elevated right heart pressure JVD Ascitis Suspects pulmonary hypertension GO Pulmonary TO EMERGENCY Embolism? ROOM!!

CASE STUDY CXR unremarkable CT Results pulmonary edema Echo Severely abnormal left ventricle Abnormal systolic function End-stage cardiomyopathy Ejection Fraction 5% Global hypokenesis

CASE STUDY June 6th, 2014 Neo-synephrine Brought emergently to Cardiac Cath Lab Dopamine Barely responsive Discolored Intubated Severely hypotensive Bradycardia Access

CASE STUDY Ejection Fraction 5%-10% LV-EDP 60 mmhg!!! No? significant obstructive CAD

BALLOON PUMP?

INTRA-AORTIC BALLOON PUMP Most widely used CIRCULATORY ASSIST DEVICE First used 40 years ago as a last result in patients in cardiogenic shock Today routinely used in a wide range of serious cardiovascular conditions Hemodynamic unstable patients Acute myocardial infarction (AMI) Cardiogenic shock High risk patients undergoing PCI M. Krishna, K. Zacharowski. Principles of intra-aortic balloon pump counter pulsation. Contin Educ Anaesth Crit Care Pain (2009) 9 (1): 24-28

INTRA-AORTIC BALLOON PUMP Aorta systolic pressure, diastolic pressure Left ventricle systolic pressure, end-diastolic pressure, volume, wall tension Heart afterload, preload, cardiac output M. Krishna, K. Zacharowski. Principles of intra-aortic balloon pump counter pulsation. Contin Educ Anaesth Crit Care Pain (2009) 9 (1): 24-28

INTRA-AORTIC BALLOON PUMP The primary goal of IABP: Improve the ventricular performance Facilitating an increase in myocardial oxygen supply Decreasing myocardial oxygen demand. IABP may also have favorable effects on right ventricular (RV) function Unloading the left ventricle Causing reduction in left atrial and pulmonary vascular pressures Decreases RV afterload. M. Krishna, K. Zacharowski. Principles of intra-aortic balloon pump counter pulsation. Contin Educ Anaesth Crit Care Pain (2009) 9 (1): 24-28

INTRA-AORTIC BALLOON PUMP IABP is not a true circulatory support device Not really a pump Does not contribute directly to cardiac output Only rapidly deployable support device available for decades R. Stretch, C. Sauer, D. Yuh, P. Bonde. National Trends in the Utilization of Short-Term Mechanical Circulatory Support -Incidence, Outcomes, and Cost Analysis. JACC (2014) VOL. 64, NO. 14.

THE BEST TREATMENT?

ASSISTANCE OR SUPPORT?

PERCUTANEOUS MECHANICAL LVADS CIRCULATORY SUPPORT DEVICES (LEFT VENTRICULAR ASSIST DEVICES)

LVADS Provide mechanical circulation when the heart cannot pump efficiently enough to maintain adequate cardiac output Used in the sickest patients: End-stage heart failure Heart failure after cardiac surgery High-risk cardiac surgery Severe Myocarditis Ventricular dysrhythmia High- Risk PCI Acute MI Sample, S. (2005). Technology today: left ventricular assist devices. Rn, 68(11),

LVADS Thoratec PVAD, ECMO Has always been reserved for emergency near-arrest situations. Significant morbidity and mortality associated with these devices Restricted their use to potential transplant candidates. R. Stretch, C. Sauer, D. Yuh, P. Bonde. National Trends in the Utilization of Short-Term Mechanical Circulatory Support -Incidence, Outcomes, and Cost Analysis. JACC (2014) VOL. 64, NO. 14.

LVADS Tandemheart Can be deployed in the cardiac cath lab. Can require a multitude of resources TEE/ ICE guidance Specialized training R. Stretch, C. Sauer, D. Yuh, P. Bonde. National Trends in the Utilization of Short-Term Mechanical Circulatory Support -Incidence, Outcomes, and Cost Analysis. JACC (2014) VOL. 64, NO. 14.

IMPELLA Worlds smallest pump Inserts like a pigtail catheter

IMPELLA Indications Cardiogenic Shock STEMI/ Cardiogenic Shock STEMI/ Urgent CABG Acutely decompensated CHF patients Temporary mechanical support patients with multi-organ failure Bridge to decision or Bridge to transplant Bridge to recovery High-Risk PCI

IMPELLA High-risk PCI Un-protected left main Single remaining vessel Compromised LV patients in cardiogenic shock

Why use it?

IMPELLA Insertion Inserts into femoral artery 13 Fr Sheath(Impella 2.5) 9 Fr catheter shaft Up to 2.5 L/ Min. 14 Fr (Impella CP) 9 Fr catheter shaft Up to 4L/ Min.

IMPELLA Protect 1 Trial Determine safety and efficacy of placement Patients having high-risk PCI, all with poor ventricular function Device was placed successfully on all patients None became hemodynamically unstable

IMPELLA PROTECT II TRIAL Results: High-risk population that underwent PCI Compared Impella with IABP Significantly lower MAE & MACCE at 90 days Major Adverse Events Major Adverse Cardiac and Cerebral Events

IMPELLA Study: STEMI complicated by cardiogenic shock on IABP No difference in 30-day mortality in patients with and without IABP No impact on 1-year mortality A. Dziewierz, Z. Siudak, T. Rakowski, et. al. Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock. (2014) 10, 3 (37): 175 18, DOI: 10.5114/pwki.2014.45144

IMPELLA Stretch Trial 1511% in use of MCS Correlate Length of Stay Mortality Hospital Costs 25% Cost/ LOS associated with IABP

CASE STUDY

CASE STUDY Impella CP was placed in Cardiac Cath lab MCVI Transferred to a transplant center A couple weeks post transfer Surgeon removed Impella CP from groin Replace with the Impella 5 - Axillary Allowed patient mobility Inpatient for a little over 2 months Discharged back to a normal life

CONCLUSION There are different choices & indications for LVADS No two patients are the same Operators decision Lots of data on the devices available Making the right decision what s best for their patient.

Thank you